Ysios Capital has raised €126.4 million for its Ysios Biofund II Innvierte, according to a SEC filing. The Barcelona-headquartered firm began fundraising in 2014 with a €100 million target.
Its previous fund raised €65 million in 2008.
Investors that committed to Ysios Biofund II Innvierte include the CDTI, the European Investment Fund and Orza.
The fund will target venture capital opportunities in biotech, medtech and diagnostic companies sectors in Europe with special interest in Spain.